Skip to main content

Peer Review reports

From: Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol

Original Submission
31 Jan 2022 Submitted Original manuscript
20 May 2022 Reviewed Reviewer Report - Maria Cecilia Darin
29 Jun 2022 Reviewed Reviewer Report - Adeyemi Okunowo
29 Aug 2022 Author responded Author comments - Xin Zhao
Resubmission - Version 2
29 Aug 2022 Submitted Manuscript version 2
22 Sep 2022 Reviewed Reviewer Report - Adeyemi Okunowo
5 Oct 2022 Author responded Author comments - Xin Zhao
Resubmission - Version 3
5 Oct 2022 Submitted Manuscript version 3
7 Oct 2022 Author responded Author comments - Xin Zhao
Resubmission - Version 4
7 Oct 2022 Submitted Manuscript version 4
Publishing
7 Oct 2022 Editorially accepted
4 Nov 2022 Article published 10.1186/s12978-022-01513-8

You can find further information about peer review here.

Back to article page